KINAXO Biotechnologies secures venture funding - MarketLine Financial Deals

KINAXO Biotechnologies secures venture funding

KINAXO Biotechnologies secures venture funding - MarketLine Financial Deals
KINAXO Biotechnologies secures venture funding
Published Nov 20, 2009
3 pages — Published Nov 20, 2009
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

KINAXO Biotechnologies GmbH, a Germany-based biotechnology company, has secured venture funding from Leifina GmbH & Co. KG and Conmit Invest GmbH.

  
Source:
Document ID
MA13479_091125
Country
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "KINAXO Biotechnologies secures venture funding" Nov 20, 2009. Alacra Store. Dec 08, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/KINAXO-Biotechnologies-secures-venture-funding-2052-18317>
  
APA:
MarketLine Financial Deals. (2009). KINAXO Biotechnologies secures venture funding Nov 20, 2009. New York, NY: Alacra Store. Retrieved Dec 08, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/KINAXO-Biotechnologies-secures-venture-funding-2052-18317>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.